Prestige Consumer Healthcare Inc. (PBH)

$59.58

+0.78 (+1.33%)
Rating:
Recommendation:
Buy
Symbol PBH
Price $59.58
Beta 0.580
Volume Avg. 0.28M
Market Cap 2.974B
Shares () -
52 Week Range 50.4-63.83
1y Target Est -
DCF Unlevered PBH DCF ->
DCF Levered PBH LDCF ->
ROE 13.75% Buy
ROA 5.60% Neutral
Operating Margin -
Debt / Equity 132.67% Buy
P/E 14.57 Strong Buy
P/B 1.90 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest PBH news


Mr. Ronald Lombardi
Healthcare
Medical Distribution
New York Stock Exchange

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.